A clinical, evidence-based risk estimator for individualizing benefit and response in oligometastatic prostate cancer (CEREBRO): A tool from the X-Met collaboration.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Alexander Dean Sherry, Piet Ost, Hyunsoo Hwang, Pavlos Msaouel, Giulio Francolini, Lorenzo Livi, Phuoc T. Tran, Ana Ponce Kiess, Jarey Wang, Ryan Phillips, Matthew Pierre Deek, Giulia Marvaso, Barbara Alicja Jereczek-Fossa, Ethan B. Ludmir, Pierre Blanchard, Ryan Sun, David A. Palma, Chad Tang
Institutions: Mayo Clinic, Ghent University, The University of Texas MD Anderson Cancer Center, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Johns Hopkins University, Johns Hopkins Medicine, Rutgers, The State University of New Jersey, University of Milan, European Institute of Oncology, Institut Gustave Roussy
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7133216346
Cites:
Cited by:
Related to: